{"contentid": 488457, "importid": NaN, "name": "Ryvu Therapeutics appoints Vatnak Vat-Ho as CBO", "introduction": "Krakow, Poland-based oncology specialist Ryvu Therapeutics today announced that Vatnak Vat-Ho has joined the company as chief business officer.", "content": "<p>Krakow, Poland-based oncology specialist Ryvu Therapeutics (WSE: RVU) today announced that Vatnak Vat-Ho has joined the company as chief business officer.</p>\n<p>In his position, Mr Vat-Ho will be responsible for a wide scope of corporate and business development activities at Ryvu including strategic positioning, partnering discussions, alliance management as well as investor interactions.</p>\n<p>Mr Vat-Ho brings to Ryvu almost 20 years of professional experience spanning pharma, biotech, as well as capital markets expertise. He spent the first 10 years of his professional career in a variety of investment banks and global equity healthcare funds, including Broadfin Capital and BMO, later moving to the pharma and biotech industry.</p>\n<p>His experience includes an eight-year tenure at Pfizer (NYSE: PFE), where he held several roles, concluding in the position of senior director/team lead, strategy, business development and alliances in the commercial development organization.</p>\n<p>Most recently Mr Vat-Ho served as vice president, business development at Affimed, a German oncohematology biotechnology company listed on the NASDAQ, where he was responsible for leading partnering activities for both the pre-clinical and clinical pipeline, as well as serving as alliance manager for the company&rsquo;s collaborations.</p>", "date": "2021-04-26 15:30:00", "meta_title": "Ryvu Therapeutics appoints Vatnak Vat-Ho as CBO", "meta_keywords": "Ryvu Therapeutics, Appointment, Vatnak Vat-Ho, Chief business officer, CBO", "meta_description": "Ryvu Therapeutics appoints Vatnak Vat-Ho as CBO", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-26 15:29:42", "updated": "2021-04-26 15:37:38", "access": NaN, "url": "https://www.thepharmaletter.com/article/ryvu-therapeutics-appoints-vatnak-vat-ho-as-cbo", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "ryvu_large.png", "image2id": "ryvu_small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Oncology", "topic_tag": "Boardroom, Management, One to Watch Companies", "geography_tag": "Poland", "company_tag": "Ryvu Therapeutics", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-26 15:30:00"}